Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia”

2 trials

Showing 2 of 2 results

Not applicableNo Longer AvailableNCT04476706
What this trial is testing

Canakinumab MAP in COVID-19 Pneumonia With CRS

Who this might be right for
Cytokine Release Syndrome in COVID-19-induced Pneumonia
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT04362813
What this trial is testing

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

Who this might be right for
Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia
Novartis Pharmaceuticals 454

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation